SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-146093
Filing Date
2024-05-23
Accepted
2024-05-23 17:10:36
Documents
15
Period of Report
2024-05-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d830013d8k.htm   iXBRL 8-K 28197
2 EX-99.1 d830013dex991.htm EX-99.1 20510
  Complete submission text file 0001193125-24-146093.txt   218285

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snse-20240523.xsd EX-101.SCH 3872
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20240523_def.xml EX-101.DEF 14097
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20240523_lab.xml EX-101.LAB 23426
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20240523_pre.xml EX-101.PRE 15130
19 EXTRACTED XBRL INSTANCE DOCUMENT d830013d8k_htm.xml XML 5603
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 24979597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)